Q1 2026 Cellebrite DI Ltd Earnings Call Transcript
Key Points
- Cellebrite DI Ltd (CLBT) reported a 21% year-over-year growth in ARR, reaching $493 million.
- The company delivered an adjusted EBITDA of $30.6 million, marking a 29% increase year-over-year.
- Cellebrite's free cash flow margin for the trailing 12 months was 32%, demonstrating strong cash generation.
- The launch of Genesis, a next-gen AI solution, has received positive feedback from over 500 early adopters across 15 countries.
- Cellebrite achieved FedRAMP high authorization, opening opportunities with US Federal agencies for its cloud offerings.
- The first quarter saw some deals being pushed, affecting the net new ARR, which remained flat year-on-year.
- There is uncertainty around the pricing strategy for the new AI products, which could impact initial monetization efforts.
- The company faces challenges in navigating larger deal sizes, particularly in the Federal space, which could delay revenue recognition.
- Cellebrite's Q1 growth was modest due to seasonality and a small population of expiring contracts.
- The geopolitical instability, while a tailwind for business, presents operational challenges, particularly in regions like Asia.
(Operator Instructions) Welcome to the Cellebrite first-quarter 2026 financial results conference call. (Operator Instructions) I would now like to turn the call over to your first speaker today, Mr. Andrew Kramer. Mr. Kramer, the floor is yours.
Thank you very much. Welcome, everybody, to Cellebrite's first-quarter 2026 financial results conference call. I'm joined this morning by Tom Hogan, Cellebrite's CEO; David Barter, Cellebrite's CFO. Also with us today are Marcus Jewell, our CRO; and Shiv Ramji, our new President of Products and Technology. This call is being recorded, and a replay of the recording will be made available on our website shortly after the call, along with a copy of the prepared remarks and transcript.
Please note that today's press release and financial statements, including GAAP to non-GAAP reconciliations, are available on the Investor Relations website at investors.cellebrite.com. In addition to the press release, we posted a separate investor presentation
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
